Advertisement
Canada markets close in 3 hours 43 minutes

  • S&P/TSX

    21,824.55
    -49.17 (-0.22%)
     

  • S&P 500

    5,022.04
    -49.59 (-0.98%)
     

  • DOW

    37,938.13
    -522.79 (-1.36%)
     

  • CAD/USD

    0.7303
    +0.0005 (+0.07%)
     

  • CRUDE OIL

    82.51
    -0.30 (-0.36%)
     

  • Bitcoin CAD

    87,694.59
    -892.62 (-1.01%)
     

  • CMC Crypto 200

    1,386.82
    +4.25 (+0.31%)
     

  • GOLD FUTURES

    2,341.80
    +3.40 (+0.15%)
     

  • RUSSELL 2000

    1,969.18
    -26.24 (-1.32%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ

    15,494.08
    -218.67 (-1.39%)
     

  • VOLATILITY

    16.54
    +0.57 (+3.56%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6810
    -0.0009 (-0.13%)
     
MARKETS LIVE BLOG:

STOCKS SLIDE AFTER META'S REALITY CHECK, WITH GDP ON DECK

Owner of Facebook and Instagram plans to spend up to US$10B on AI infrastructure investments

Danaher wins conditional EU okay for $21 billion biopharma buy

Reuters

BRUSSELS (Reuters) - U.S. medical equipment maker Danaher <DHR.N> secured conditional EU approval on Wednesday for its $21.4 billion bid for General Electric's <GE.N> biopharma business after agreeing to sell five businesses to address competition concerns.

Danaher unveiled the deal in February, which will boost its presence in the biopharma industry, giving it access to tools for research and development of drugs.

The European Commission said Danaher will sell businesses in the United States, China, France and Britain after it voiced concerns that the deal would have reduced competition and pushed up prices of certain products in some markets.

(Reporting by Foo Yun Chee)